Evidence map›Paper›PMID 36135832›Full record

ArticleMedical sciences (Basel, Switzerland)2022

Identification and Characterization of Novel Small-Molecule SMOX Inhibitors.

Amelia B Furbish, Ahmed S Alford, Pieter Burger, Yuri K Peterson, Tracy Murray-Stewart, Robert A Casero, Patrick M Woster

Open access · goldAbstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Biomolecules · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amelia B FurbishDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA.ORCID 0000-0002-3877-7937
Ahmed S AlfordDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA.ORCID 0000-0002-7311-0767
Pieter BurgerDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA.
Yuri K PetersonDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA.ORCID 0000-0002-4005-9678
Tracy Murray-StewartSidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins School of Medicine, 1650 Orleans St. Room 551, Baltimore, MD 21287, USA.ORCID 0000-0001-8679-6414
Robert A CaseroSidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins School of Medicine, 1650 Orleans St. Room 551, Baltimore, MD 21287, USA.ORCID 0000-0001-5653-3306
Patrick M WosterDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA.ORCID 0000-0002-9471-1916
Medical University of South Carolina · USJohns Hopkins University · US

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR001451 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2015 to 2024
$4.6M
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention targetR01CA204345 · NCI · JOHNS HOPKINS UNIVERSITY · PI CASERO, ROBERT A., WOSTER, PATRICK M · 2016 to 2020
$3.4M
NCATS NIH HHS TL1 TR001451NCATS NIH HHS UL1 TR001450NCI NIH HHS R01 CA204345
6 · The paper itself

Abstract

The major intracellular polyamines spermine and spermidine are abundant and ubiquitous compounds that are essential for cellular growth and development. Spermine catabolism is mediated by spermine oxidase (SMOX), a highly inducible flavin-dependent amine oxidase that is upregulated during excitotoxic, ischemic, and inflammatory states. In addition to the loss of radical scavenging capabilities associated with spermine depletion, the catabolism of spermine by SMOX results in the production of toxic byproducts, including H

Indexed as

Oxidoreductases Acting on CH-NH Group DonorsSpermineAcroleinFlavinsHydrogen PeroxidePolyamine OxidasePolyaminesSpermidineAcroleinFlavinsHydrogen PeroxideOxidoreductases Acting on CH-NH Group DonorsPolyamine OxidasePolyaminesSpermidineSpermineacroleinexcitotoxicityneuronal injuryoxidative stresspolyamine oxidasepolyaminesspermine oxidase

Identifiers

PMID36135832
PMCPMC9504029
OpenAlexW4293773304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.